The Case Against Chronic High-Dose Probiotic Supplementation
by Mark A. Brudnak and Eric J. Baer
The human body contains a wide variety of bacteria; estimates generally range anywhere from 500 to 1000 different species as normal residents. What we have learned is that some are “good” and some are “bad.” However, a better way of thinking about this is to say that some appear good and some appear bad. The line between “good” and “bad” bacteria has become blurred as of late with the discovery that even pathogenic bacteria are usually present and can confer beneficial effects on the immune system.
Previously, I’ve written about the use of probiotics for things such as yeast infections, lactose intolerance, and irritable bowel syndrome.1 Further, I’ve covered the detoxification of substances such as mercury and a pulsing-and-rotating methodology for probiotics.2,3 As part of the latter, the basic idea was that there may be some select occasions for wanting high-dose probiotics but that usually what one would rather select is a lower “maintenance” dose with periodic rotation of the strains. This article is not about banishing of high-dose probiotics but rather putting them into perspective and understanding their limits.
Some high-dose products on the market may use a variety of organisms. Many of these organisms are standard probiotics. Some can be potentially dangerous varieties, such as Bacillus subtilis or Enterococcus faecium. The dangers of the Bacillus subtilis, should be obvious, but E. faecium is more interesting from the perspective of molecular biology. Most of these organisms harbor plasmids, small covalently closed circular extrachromosomal pieces of DNA. E. faecium is one plasmid away from being Enterococcus faecalis. The plasmid that E. faecalis harbors, in which E. faecium is deficient, carries the genes for vancomycin resistance. All that needs to happen is a conjugal transfer of the plasmid from E. faecalis to one of the other probiotics, and disaster could ensue. There are now published reports of just that sort of transfer happening.4–7
It’s important to understand there are times and places for everything, including high-dose probiotics. Ten years ago, most probiotic products contained either Lactobacillus acidophilus or Bifidobacterium lactis (bifidum). If one was really lucky, one could find a combination of the two and possibly a couple of yogurt strains (i.e., Lactobacillus bulgaricus) thrown in. Many of these contain only a few hundred million viable cells at the time of manufacture. While that may sound like a lot of organisms, especially when we are conditioned to think of bacteria as being “bad,” current data tell us that those numbers were probably far too low to be doing very much good. This is true at least in the short-term, therapeutic application of the probiotics.
As more and more data come in, it is becoming apparent that at least 1 billion organisms per dose are needed to achieve any real clinical significance. In one study, 10 billion Bifidobacteria in milk were given per day and immune markers measured.8 A significant increase in phagocytic activity of granulocytes was observed.
In a randomized, double-blind, placebo-controlled study, the prophylactic effect of probiotics on infections in neutropenic patients undergoing cytoreductive chemotherapy for acute leukemia was studied. Thirty patients (35 episodes) were included in the study. The lactobacilli were given as 2 capsules thrice daily for 30 days, starting at the initiation of chemotherapy. The occurrence of fever was significantly (p = 0.033, Mann-Whitney rank sum test) postponed from a median time of 8 to 12 days. Each capsule contained 4 billion (50/50 Bifidobacterium lactis/lactobacillus acidophilus) bacteria per capsule.9
In addition to immune parameters, the reduction of circulating ammonia has also been observed by Deguchi et al., using 5 billion organisms of either B. lactis or B. breve in cecal contents.10 They also observed a corresponding drop in the pH of the cecal contents. This lends support for the use of probiotics in detoxification protocols, which has been reported elsewhere.11
Probiotic supplementation has been demonstrated to be very safe and effective for a wide variety of disturbances, including antibiotic side effects, diarrhea/constipation, lactose malabsorption, and cholesterol reduction. Dosages ranging from 1 to almost 500 billion organisms have been used without complications.12,13 Current trends seem to indicate a range of 10 to 100 billion live organisms as being efficacious for the variety of conditions mentioned above. At least two different companies have “high-dose” products on the market, with 20 and 30 billion organisms per capsule. These products should serve as a portent, as they were both originally designed for different markets: the environmentally challenged and autism (and Down syndrome), respectively. These are excellent demonstrations of two developing principles. First, there is a need for high-dose probiotics to treat selective conditions. Second, there is the need for a variety of products. Ideally, one would have formulas for adults, children, weight loss, immune system, and the colon, to mention a few.
What we are learning is while a low-dose run-of-the-mill L. acidophilus (providing that it is well produced) can be great for a general maintenance program, sometimes a much higher dose is required to achieve clinical significance. Additionally, it is becoming increasingly apparent that the inclusion of other strains, such as Lactobacillus rhamnosus or Lactobacillus plantarum, can have a dramatic effect.14–16 The inclusion of multiple strains is not only beneficial for the specific conditions but also may play another important role in the application of probiotics.
With the use of mono- or bi-strain products, there are reports of reduction in effects over time. For instance, in the case of autism, a child, who pretreatment had either diarrhea or some other gastrointestinal distress, improves dramatically when first supplemented with those products. The child starts regularly producing well-formed stools. However, in some cases, the child can revert to the previous distressed state. Two approaches seem to have found a resolution for this consternating phenomenon.
The first approach is the “pulse” method. Here, when the effect begins to change, the probiotic supplementation can be ceased for a period of time, followed by a repeat application. The body appears to be “resetting” itself after cessation of the therapy. During this period, changes are occurring in the gastrointestinal tract that may be making the local environment more hospitable to the probiotics. Additionally, there are certainly changes in the immune functioning of the gut.
It is well established that the intestines are a major source of immune competence.17 It is also well established that there are genetic elements that respond to heavy metals, and in particular to mercury.18 What may be happening is that upon initial exposure to the probiotics, the gut-associated immune system is mobilized and may be attacking them. After withdrawal of the probiotics, the immune reaction tapers off until any subsequent exposure. This is not a bad thing and can be used efficaciously by pulsing the probiotics. Also, a variation on that theme can be employed. Instead of withdrawing all probiotics for any period of time, substituting another product that contains different organisms would seem the logical next step.
For instance, if a product that contains only L. rhamnosus is being used and the above condition presents, a product of just Bifidobacterium could be employed. If a single strain of Bifidobacterium is used, and again the same situation occurs, then a third product with several strains could be administered. It most certainly is going to have to go on a case-by-case basis, according to the physician’s observations. In the foreseeable future, there will be products designed specifically to address the issue in this way. This “probiotic rotation” will apply in a variety of situations.
As can be seen, the area of probiotics is still in its infancy. This neonate is soon to grow up, however, as major pharmaceutical companies enter this exciting and efficacious area of health care. As clinical data from the application of probiotics to conditions such as autism, Down syndrome, cancer, lactose intolerance, and so on, come to light, consumer/patient demand for awareness of the importance of these organisms will concomitantly increase. With that, we can expect better products tailored to specific conditions to also be developed. This is currently happening, but the market competition is forcing the cell counts needlessly higher and higher.
On the high-dose note, more is not always better. We’ve probably seen the peak of the high-dose levels that we are going to see, because when you ferment the bacteria, the highest cell count that you can get per gram is usually about 1 trillion. That sounds like a lot, but when we have products at 400 to 500 billion per capsule, that is already at the upper level of the technical feasibility.
When you think about probiotics, what you need to be thinking is: more isn’t better, but less can be. How can fewer bacteria work for you? The way that you need to think about that is to remember that within the human body, inside the intestines, is an ecosystem. As a metaphor, imagine putting a drop of food dye in a glass of water. When you do so, what happens? The dye starts to spread out, to places where it had not existed before it was added to the water. So the whole glass eventually becomes pinkish: not the same red as the dye, and not the same clear water.
When you ingest a capsule of probiotics, the bacteria enter your digestive system much like a drop of dye enters water; the capsule begins breaking down and at some point fully releases, and the bacteria spread out similarly to the way that dye spreads out. But unlike the dye, the bacteria live and die. Another key difference is that the water is uniform throughout the glass. The digestive system is very different; every inch of it slightly changes from the microenvironment next to it. This change is due to variables such as pH, nutrients, and microbes present. The bacteria, unlike food coloring, have to adapt to each microenvironment in order to thrive there.
The process of life involves mutations. As those bacteria live, they themselves suffer mutations, which may change functions and subsequent multiplications and can further result in mutations. So everything is moving around inside the body and constantly changing. As the environment changes, bacteria with best-suited mutations are selected and occupy those new niches. As this happens, all the available niches become filled or at least occupied by beneficial bacteria vs. being occupied by pathogenic bacteria. This involves processes known as genetic drift and natural selection.
Genetic drift drives evolution. Technically defined: “Genetic drift or allelic drift is the change in the frequency of a gene variant (allele) in a population due to random sampling.”19 That mouthful is just a precise way of saying, a drop of the red dye spreads in a glass of water. In other words, if bacteria are making something that creates a healthier body, which allows them to flourish even more, then over time those bacteria get selected for. Things change over time – and by time we mean short time. Bacteria can double their number in 10 minutes in some cases, depending on the nutrients available. Probiotics take a little longer, but compared with the human lifespan, it’s a blink of an eye. So what happens over time is each that one of those cells duplicates itself. Every time that a cell does this, there is the probability that an error in the genetic code is made. These errors occur randomly every single time. There are error-correcting mechanisms, but they are not 100% effective. Those errors eventually add up to the point where the subsequent bacteria can’t live. During that time, they change – and can change substantially. Sometimes, for instance, they may make an enzyme that works better, sometimes one that functions less well. This is all due to mutations.
Each time a mutation occurs is like that glass of water changing. The color is dispersing throughout the entire system. The same is true for bacteria. If bacteria in the upper part of the GI survive better by making a protease 100 times stronger than a normal protease, those bacteria will be selected for. If bacteria in the lower GI, just for the sake of argument, can survive better by making a much weaker protease and maybe a stronger lipase, then those bacteria will get selected in that region. Either way, those niches have bacteria that have changed from the initial sample that was ingested.
A good way to visualize this is in Figure 1. The population has some sort of selective pressure placed on it, just as our gastrointestinal tracts do based upon what we ingest, breathe, and produce in our own bodies. The selective pressure causes the population to drift to the left. Keep in mind that the population could easily have been put under another sort of pressure that would shift it to the right. It all depends on the conditions inside the gut.

Figure 1
: This is a representation of genetic drift for a population of bacteria. Series 1 is the original population, Series 2 is the “drifted” population. As can be seen, there is a population shift to the left.
When looking at a graph like this, the populations represented by Series 1 and Series 2 are collections of bacteria. Just as all humans don’t look all the same, neither do bacteria; but they are still bacteria. The X-axis represents diversity of some sort. The Y-axis represents numbers of bacteria. That is why a bell-shaped curve results when the data are plotted.
So why is less better? The answer is, if too large a quantity of probiotics is taken, if that glass of water gets blasted with a whole bottle of food dye, the water will be nothing but red. There won’t be any chance for the niches to be filled with unique bacteria best suited to be there because you are constantly overwhelming the system with just one or a relatively few different types of bacteria. If one takes these every day, the correct bacteria – those that your body needs and has evolved to live in a healthy relationship with – never get a chance to come into existence.
For instance, if one ingests a high dose of acidophilus today and a stool sample is taken a week or two later, slightly different acidophilus strains will be found than originally ingested. This is because the purpose of life, from a biological perspective, is to perpetuate genetic material; in the case of bacteria, that’s the DNA. That is why the bacteria fill in all the niches. It’s Nature’s shotgun approach to survival. Nature throws everything that it can into a system with the hopes that something will survive. If there is a fillable niche, Nature will always fill it.
There is a constant flux within the body. To keep it simple, say we have only 4 different bacteria in us: A, B, C, and D. (We actually have 500–1000 different types of bacteria in us at all times). Sometimes A may predominate, sometimes B. Due to environmental stresses – what you eat and breathe, viruses, and so on – the numbers of each bacteria are constantly changing. When you are sick, your stools are different from when you are healthy. This is a biological signal indicating a shift in the bacterial populations inside you.
Circling back, it is now clear that the notion of “the higher the bacterial concentration in a product, the better” is outdated. The idea here is that you want to start the race, not finish it, for the bacteria. The logical corollary is, why bother taking probiotics more than once then? The answer is simple: These populations do fill in niches, but they also continue to change and grow older, weaker, and less effective. If the supply of fresh lower maintenance dose probiotics continues, it allows the older ones to safely die off and be replaced by the newer fresh ones that will then grow (be selected) into the niches of the older ones and thus prevent “bad” bacteria from getting established in that niche. This is accomplished without blasting away all the populations in the GI via high-dose products.
There is a war going on over real estate and nutrients inside you (i.e., the lining of the gastrointestinal tract and the bolus moving through it). In keeping with the metaphor, if we have a land war, it doesn’t make much sense to send in billions of navy ships. Why would you want to do that with probiotics unless under very special circumstances? The answer is, you don’t.
Notes
1. Brudnak MA. The Probiotic Solution. St. Paul, MN: Dragon Door Publications; 2003.
2. Brudnak MA. Probiotics as an adjuvant to detoxification protocols. Med Hypotheses. 2002 May;58(5):382–385.
3. Brudnak MA. Probiotic applications: pulse and rotation. Townsend Lett. October 2001.
4. Tannock GW. Conjugal transfer of plasmid pAM beta 1 in Lactobacillus reuteri and between lactobacilli and Enterococcus faecalis. Appl Environ Microbiol. 1987 Nov;53(11):2693–2695.
5. Elsner HA, Sobottka I, Feucht HH, et al. Nosocomial outbreak of vancomycin-resistant Enterococcus faecium at a German university. Pediatric Int J Hyg Environ Health. 2000 Oct;203(2):147–152.
6. Elsner HA, Sobottka I, Mack D, Claussen M, Laufs R, Wirth R. Virulence factors of Enterococcus faecalis and Enterococcus faecium blood culture isolates. Eur J Clin Microbiol Infect Dis. 2000 Jan;19(1):39–42.
7. Suppola JP, Kolho E, Salmenlinna S, Tarkka E, Vuopio-Varkila J, Vaara M. VanA and vanB incorporate into an endemic ampicillin-resistant vancomycin-sensitive Enterococcus faecium strain: effect on interpretation of clonality. J Clin Microbiol. 1999 Dec;37(12):3934–3939.
8. Schiffrin et al. J Dairy Sci. 1995;78:491–497.
9. Deguchi Y et al. Microbial ecology in health and disease. 1994;6:85–94.
10. Brudnak MA. High-dose probiotics for detoxification .Townsend Lett. Nov. 2002.
11. Presented at the Seventh International Symposium on Infections in the Immunocompromised host. June 21–24, 1992; Boulder, Colorado, US.
12. Hove H, Nordgaard-Andersen I, Mortensen PB. Effect of lactic acid bacteria on the intestinal production of lactate and short-chain fatty acids, and the absorption of lactose. Am J Clin Nutr. 1994 Jan;59(1):74–79.
13. Gaon D et al. Lactose digestion by milk fermented with human strains of Lactobacillus acidophilus and Lactobacillus casei. 1995. Medicina (Buenos Aires). 55:237–242.
14. Mangiante G, Colucci G, Canepari P, et al. Lactobacillus plantarum reduces infection of pancreatic necrosis in experimental acute pancreatitis. Dig Surg. 2001;18(1):47–50.
15. Marteau PR, de Vrese M, Cellier CJ, Schrezenmeir J. Protection from gastrointestinal diseases with the use of probiotics. Am J Clin Nutr. 2001;73:430S–436S.
16. Gregor Reid Probiotic agents to protect the urogenital tract against infection. Am J Clin Nutr. 2001;73:437S–443S.
17. Brudnak MA. Application of genomeceuticals to the molecular and immunological aspects of autism. Med Hypotheses. 2001 Aug;57(2):186–191.
18. Badou A, Savignac M, Moreau M, et al. HgCl2-induced interleukin-4 gene expression in T cells involves a protein kinase C-dependent calcium influx through L-type calcium channels. J Biol Chem. 1997 Dec 19;272(51):32411–324118.
19. Masel J. Genetic drift. Current Biol. 2011;21(20):R837–R838. doi:10.1016/j.cub.2011.08.007.
Corresponding author:
Eric J. Baer
1235 Dakota Dr.
Grafton, WI 53024
eric@makwood.com









0 Comments